Skip to content

CGEM

Cullinan Therapeutics, Inc.

NASDAQ · USHealthcareMedical - Pharmaceuticals
$17.73+0.20%

Price as of Jul 20, 2026

CGEM earnings

Cullinan Therapeutics, Inc. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 6, 2026in NaN days
EPS est $-0.80 · Revenue est $4M
Track record
Beat EPS in 9 of 12 quarters
Avg surprise +1.3% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$-0.84$-0.75+10.3%
Mar 10, 2026$-0.81$-0.77+4.9%
Nov 6, 2025$-0.95$-0.77+18.9%
Aug 7, 2025$-0.83$-1.07-28.9%
May 8, 2025$-0.78$-0.74+5.1%
Feb 27, 2025$-0.75$-0.73+2.7%
Nov 7, 2024$-0.78$-0.69+11.5%
Aug 8, 2024$-0.73$-0.75-2.7%
May 15, 2024$-0.90$-0.86+4.4%
Mar 14, 2024$-0.96$-0.54+43.7%
Aug 10, 2023$-0.99$-0.82+17.2%
May 11, 2023$-0.84$-1.42-69.0%

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.